Astrana Health (NASDAQ:ASTH) Trading 3.9% Higher – What’s Next?

Astrana Health, Inc. (NASDAQ:ASTH)’s stock price rose 3.9% during mid-day trading on Tuesday . The company traded as high as $31.66 and last traded at $31.81. Approximately 130,682 shares were traded during mid-day trading, a decline of 48% from the average daily volume of 249,187 shares. The stock had previously closed at $30.60.

Wall Street Analyst Weigh In

ASTH has been the subject of a number of recent research reports. Bank of America dropped their price objective on shares of Astrana Health from $55.00 to $49.00 and set a “buy” rating for the company in a research note on Tuesday, March 4th. Macquarie raised shares of Astrana Health to a “hold” rating in a research note on Monday, December 16th. Truist Financial cut their price target on shares of Astrana Health from $50.00 to $46.00 and set a “buy” rating on the stock in a report on Tuesday. Stifel Nicolaus decreased their price objective on shares of Astrana Health from $70.00 to $56.00 and set a “buy” rating for the company in a research note on Thursday, February 20th. Finally, Robert W. Baird cut their target price on Astrana Health from $86.00 to $50.00 and set an “outperform” rating on the stock in a research note on Monday, March 3rd. Two investment analysts have rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $56.17.

Astrana Health Stock Down 2.2 %

The firm has a market capitalization of $1.73 billion, a PE ratio of 23.71, a PEG ratio of 1.37 and a beta of 1.30. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.91 and a current ratio of 1.91. The company has a fifty day simple moving average of $33.96 and a two-hundred day simple moving average of $42.76.

Astrana Health (NASDAQ:ASTH) last issued its earnings results on Thursday, February 27th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.22 by ($0.37). Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. The business had revenue of $665.21 million for the quarter, compared to the consensus estimate of $617.24 million. Analysts forecast that Astrana Health, Inc. will post 1.15 EPS for the current fiscal year.

Institutional Trading of Astrana Health

Hedge funds have recently bought and sold shares of the stock. Pilgrim Partners Asia Pte Ltd purchased a new stake in shares of Astrana Health during the fourth quarter valued at about $40,000. Quarry LP raised its position in shares of Astrana Health by 35.5% in the 4th quarter. Quarry LP now owns 1,799 shares of the company’s stock valued at $57,000 after purchasing an additional 471 shares during the last quarter. KBC Group NV acquired a new stake in Astrana Health in the 3rd quarter worth approximately $70,000. Quest Partners LLC purchased a new stake in Astrana Health during the 3rd quarter worth approximately $133,000. Finally, US Bancorp DE increased its stake in Astrana Health by 3,880.0% during the 4th quarter. US Bancorp DE now owns 4,776 shares of the company’s stock valued at $151,000 after purchasing an additional 4,656 shares in the last quarter. Hedge funds and other institutional investors own 52.77% of the company’s stock.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.